Scleroderma, Systemic Recruiting Phase 1 Trials for Nintedanib (DB09079)

Also known as: Systemic Scleroderma

IndicationStatusPhase
DBCOND0028174 (Scleroderma, Systemic)Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03675581A Study to Test Whether Nintedanib Influences the Components of Birth-control Pills in Women With Systemic Sclerosis Associated Interstitial Lung Disease (SSc-ILD)Treatment